ArticleIJID regions2026
Community-based sentinel surveillance for Mpox-like disease among men who have sex with men and transgender individuals in India: a cross-sectional study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sentinel serosurvey for Mpox virus infection among key populations in India: Evidence of sporadic past exposure beyond travel-related cases.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Mpox emerged as a significant public health threat beyond endemic regions during 2022-2023, with sustained transmission among men who have sex with men (MSM) and transgender populations. Community-based surveillance may improve case detection in high-risk groups. Methods: A cross-sectional sentinel surveillance study was conducted from October 2023 to February 2024 across seven community-based organizations in six geographic zones of India. Clinic attendees (n = 1796) were screened for Mpox-like disease (MPLD) using WHO/Centers for Disease Control and Prevention (CDC) case definitions. Suspected cases underwent clinical evaluation, sample collection, real-time polymerase chain reaction (PCR) testing for Mpox virus (Mpoxv) DNA, and serological testing for anti-Mpox immunoglobulin (Ig) G and IgM antibodies. Results: Six (0.33%) individuals met MPLD criteria. All were young, urban MSM (median age 26 years) without previous smallpox vaccination. Most presented with genital/perianal lesions and systemic symptoms. All PCR tests were negative for Mpoxv DNA. One (16.7%) participant was IgG-positive, which may indicate previous exposure; however, the possibility of cross-reactivity with other Orthopoxviruses cannot be excluded. Contact tracing of 15 individuals identified no additional cases. Conclusion: This study demonstrates the feasibility of community-based sentinel surveillance for MPLD in high-risk populations. No PCR-confirmed Mpox cases were identified; however, the findings provide insights into clinical and behavioral patterns, supporting early detection and preparedness efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.